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Introduction 
Obstetric significance of oligohydramnios appearing in the last 
period of pregnancy is well known. Mid-trimester oligohydramnios 
observed in the second trimester is a rarer condition, and its 
management is rather ambiguous. It is often connected with life-
incompatible urinary tract malformations, but the pregnancies 
result mostly in miscarriage or perinatal death also in the lack 
of malformation. Reviewing the attainable literature, one can 
learn of only 16 healthy newborns surviving the perinatal period 
among the more than 12 0 cases reported. 
In our study we analyse our 182 cases in similar respects, and, 
in addition, try to find a connection between maternal serum 
alpha-fetoprotein concentration (MSAFP) and the outcome of 
pregnancies. 
Materials and methods 
In the last six years we performed screening ultrasound examina-
tions at 18th-20th weeks of gestation in more than 65 000 preg-
nancies. Oligohydramnios was diagnosed when the largest amniotic 
fluid pocket was no greater than 1 cm in any vertical plane. If 
no life-incompatible malformation was seen, ultrasound was re-
peated 2-3 weeks later, and only the repeatedly detected, defi-
nite cases were included, except if meanwhile a spontaneous 
abortion occurred. 
Preceding trie ultrasound MSAFP was measured at 16th week of 
gestation in a great part of patients, accordingly to our 
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regional screening program (7). 2.5 MoM (multiple of median) or 
higher AFP concentrations were considered to be elevated. 
Patients with multiple pregnancy or intrauterine demise revealed 
symptoms of premature rupture of membranes were also excluded. 
Elective pregnancy termination was advised if a life-incompatible 
malformation was obviously demonstrated, or serial ultrasound 
showed progression (no fluid, massive deformations, growth 
ceased, bradycardia). The overwhelming majority of couples has 
accepted this. Our proposals were not influenced by the MSAFP 
results. 
Terminations (and frequently miscarriages and deliveries) 
occurred mostly in our institute, and detailed fetal pathological 
examinations were performed. Pregnancy outcome data were 
collected also from other institutes in each case. 
Results 
Considering the conditions mentioned above oligohydramnios was 
found in 182 mid-trimester pregnancies. Elective pregnancy termi-
nation was performed in 103 cases. 79 pregnancies (100%) contin-
ued, but 23 of them (29%) resulted in spontaneous abortion, 14 
(18%) in missed abortion, 9 (11%) in intrauterine death, and 11 
newborns (14%) died in the perinatal period. 22 newborns (28%) 
survived, this is 12% of the all cases. Congenital malformation 
was detected as pathological background of oligohydramnios in 
78 cases (43%). 
MSAFP was measured in 65 % of pregnancies. Taking into account 
only these cases, MSAFP was normal (or low) in 19 of the 21 
surviving cases (91%), and elevated in two cases (9%). On the 
other hand, 15 of the 27 spontaneous and missed abortions were 
preceded by an elevated MSAFP value (56%). Concerning the cases 
with malformation, it is noteworthy, that MSAFP was normal (or 
low) in 12 patients of the 13, who gave birth to fetuses with 
bilateral multicystic kidneys (type Potter II). 
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Outcome of pregnancies with different MSAFP is demonstrated in 
Table 1. In the group with MSAFP under 2.5 MoM there were 19 
surviving infants (29.7%) , whereas in the other one with 
elevated MSAFP only two (3.6%). In four cases of the first group 
partial urethral obstruction caused the abnormal ultrasound 
findings, then the postnatal treatment was successful. The 
others had no anomalies. 
Table 1. Outcome of Pregnancies Complicated by Second Trimester 
Oligohydramnios 
MSAFP at 16th elective spontaneous peri- alive T 
week pregnancy and missed natal after 0 
termination abortion death the peri- T 
natal A 
period L 
determined/all 59/103 27/37 12/20 21/22 119/ 
cases 182 
A)Number 
of cases 26 12 7 19 64 
N 
0 L (%) (40.6) (18.7) (10.9) (29.8) (100) 
R o 0 
M r WX 
A No primary 
L B)malforma- 14 11 5 15 45 
tion by 
ultrasound (31.2) (24.4) (11.1) (33.3) (100) 
(%) 
A) Number of 
E cases 33 15 5 2 55 
L (%) (60) (27.3) (9.1) (3.6) (100) 
E 
V . . 
A B)No primary 
T malforma- 23 15 3 2 43 
E tion by 
Dxx ultrasound (53.5) (34.9) (7.0) (4.6) (100) 
(%) 
x < 2.5 MoM 
xx > 2.5 MoM 
Table 2. demonstrates the accuracy of MSAFP level for predicting 
abnormal outcome, t-akinq into account: the .^-^ QOC .->c i irnc -\\ 
lines b) of table 1., and lines b) excluding elective pregnancy 
terminations, respectively. High values of specificity and ' 
positive predictive values are impressive. 
J. Perinat. Med. 19 (1991) Suppl. 1 
400 
Table 2. Accuracy of MSAFP for Predicting Abnormal Outcome of 
Pregnancies Complicated by Oligohydramnios in the Second 
Trimester 
Concerned Speci- Sensi- Positive 
-"•"•'ip? ficity tivitv predictive . .. . 
All cases 
with oligo-
hydramnios 90.5% 54.1% 96.3% 29.6% 
and MSAFP 
determined 
Oligohydramnios 
without ultra-
sonically 88.2% 57.1% 95.3% 33.3% 
detectable 
malformation 
Elective 
pregnancy 88.2% 52.9% 90.0% 48.4% 
terminations 
excluded 
Abnormal outcome is defined as spontaneous and missed abortion, 
perinatal death and elective pregnancy termination. Elevated 
MSAFP was used to predict abnormal outcome. 
Discussion 
Oligohydramnios diagnosed in the second trimester means an espe-
cially poor prognosis. Barrs et al (2) reported on a series of 
38 pregnancies of their own and of the literature, and only one 
of them had a normal outcome. There were 8 surviving newborns 
among the 34 cases of Mercer et al (6). Our material shows a 
similar prognosis (22/182). 
It is a more difficult task for the counselling obstetrician, 
if no life-incompatible malformation can be seen on ultrasound. 
Though the prognosis is unfavourable also in such cases, live 
births of normal children can often occur. (As regards our 
material, 18/121.) Therefore it seems to be necessary to search 
other factors, that can help us to manage these pregnancies. 
MSAFP evaluation is extensively used for screening of neural 
tube defects. Regardless of this, elevated MSAFP means a higher 
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risk for the pregnancy outcome in a general sense (low birth-
weight, fetal distress, perinatal death) (4). 
There have been a limited number of cases reported in which ele-
vated MSAFP levels and second trimester oligohydramnios coexist 
(1,3,5,8-10). However, these authors have not studied oligo-
hydramnios cases with normal MSAFP. Others (2,6) avoid this 
preselection of patients, but do not measure MSAFP level at all. 
There is no preliminary report on the comparison of outcome with 
elevated and normal MSAFP. Reviewing the literature mentioned 
above, there were 7 of 52 pregnancies producing surviving infants 
in the group with elevated MSAFP, and 9 of 72 in the unselected 
group. 
For what reason can one suppose a connection between oligohydram-
nios and elevated MSAFP? Except of neural tube defects, elevation 
of MSAFP can occur through the damage of barrier function of 
placenta or membranes (haemorrhagia, necrosis of subclinical 
degree, incomplete rupture of membranes). This can result in an 
elevation of MSAFP, loosing of the dynamic balance of amniotic 
fluid circulation, oligohydramnios, then intrauterine demise, 
abortion, birth of premature newborn with hypoplastic lungs (3). 
The extension of these pathophysiological processes can be very 
variable, and this corresponds to the low value of sensitivity 
of MSAFP evaluation to screen adverse outcome. However, the high 
specificity and positive predictive value convince us that the 
elevation of MSAFP and the mid-trimester oligohydramnios with 
extrafetal origin are closely related. 
On the basis of our data we propose to take MSAFP into considera-
tion when no primary malformation can be detected by ultrasound 
in a mid-trimester oligohydramnios case. Pregnant women with 
more than 2.5 MoM MSAFP should be treated for threatening 
abortion even if they have no symptoms. If the couple gets to 
know the poor prognosis in due time, more time will be left to 
accept the idea of elective pregnancy termination in the case 
when the oligohydramnios proves to be progressive. 
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